TargTex

Big Idea

TargTex is a drug development company focused on developing clinical candidates for different therapeutic indications. The company’s most advanced product is a therapy for Glioblastoma Multiforme (GBM), the most aggressive type of brain tumor with high lethality and considered an unmet medical need. This product is based on a natural product with a specific formulation that already demonstrated high efficacy in pre-clinical animal models of the disease.

Year Invested

2019

Activity Highlights

Awards:

  • The best of 2019 in Portugal Technological from Exame Informática magazine: Honorable Mention in the category: Software

Patent:

  • WO/2019/054891 TRPV2 Antagonists

Sector

Therapeutics

Stage

Seed

Team

João Seixas – CEO; Pedro Cal – COO; Gonçalo Bernardes – Scientific Director.

Portugal Ventures Investment Manager

Raúl Saraiva